Viewing Study NCT03053466


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-01-10 @ 1:01 PM
Study NCT ID: NCT03053466
Status: COMPLETED
Last Update Posted: 2022-05-09
First Post: 2017-01-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors
Sponsor: Apollomics (Australia) Pty. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module